Dimensional Fund Advisors
RPRX icon

Dimensional Fund Advisors’s Royalty Pharma RPRX Stock Holding History

Dimensional Fund Advisors’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$38.1M Sell
653,563
-402,791
-38% -$23.8M 0.01% 1716
2026
Q2 		$59.3M Sell
1,056,354
-22,011
-2% -$1.15M 0.01% 1499
2026
Q1 		$51.7M Sell
1,078,365
-1,233,763
-53% -$54M 0.01% 1483
2025
Q4 		$89.4M Buy
2,312,128
+211,638
+10% +$8.07M 0.02% 1156
2025
Q3 		$74.1M Buy
2,100,490
+205,498
+11% +$7.44M 0.02% 1287
2025
Q2 		$68.3M Buy
1,894,992
+179,605
+10% +$5.95M 0.02% 1306
2025
Q1 		$53.4M Buy
1,715,387
+34,852
+2% +$1.1M 0.01% 1435
2024
Q4 		$42.9M Buy
1,680,535
+580,787
+53% +$15.4M 0.01% 1601
2024
Q3 		$31.1M Buy
1,099,748
+312,491
+40% +$8.66M 0.01% 1778
2024
Q2 		$20.8M Buy
787,257
+139,761
+22% +$3.87M 0.01% 1936
2024
Q1 		$19.7M Buy
647,496
+18,927
+3% +$558K 0.01% 1995
2023
Q4 		$17.7M Buy
628,569
+126,705
+25% +$3.48M 0.01% 2048
2023
Q3 		$13.6M Buy
501,864
+99,317
+25% +$2.95M ﹤0.01% 2102
2023
Q2 		$12.4M Buy
402,547
+12,588
+3% +$426K ﹤0.01% 2163
2023
Q1 		$14.1M Buy
+389,959
New +$14.5M ﹤0.01% 2075
2022
Q3 		$13.5M Buy
335,439
+42,479
+14% +$1.81M 0.01% 2033
2022
Q2 		$12.3M Buy
292,960
+8,019
+3% +$329K ﹤0.01% 2108
2022
Q1 		$11.1M Buy
284,941
+54,740
+24% +$2.15M ﹤0.01% 2246
2021
Q4 		$9.17M Buy
230,201
+69,686
+43% +$2.71M ﹤0.01% 2340
2021
Q3 		$5.8M Buy
160,515
+151,369
+1,655% +$5.88M ﹤0.01% 2544
2021
Q2 		$375K Sell
9,146
-295
-3% -$12.5K ﹤0.01% 3217
2021
Q1 		$413K Buy
+9,441
New +$448K ﹤0.01% 3176

Other funds holding RPRX

Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
Achmea Investment Management
Achmea Investment Management Zeist, Netherlands $12.6B AUM 25.68% 1-Year Est. Return
Eastern Bank
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
Fideuram Asset Management (Ireland)
Fideuram Asset Management (Ireland) Dublin 1 $4.57B AUM 30.36% 1-Year Est. Return

Dimensional Fund Advisors's RPRX Position: Q3 2026 in Review

Dimensional Fund Advisors reduced its Royalty Pharma (RPRX) stake by 38% in Q3 2026, selling an estimated $23.8M and leaving 653,563 shares worth $38.1M. The position accounts for 0.01% of the portfolio, ranked #1716.

Dimensional Fund Advisors first reported a position in RPRX in Q1 2021 and has held it in 22 quarters since. The position peaked at $89.4M in Q4 2025. 275 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Dimensional Fund Advisors held 653,563 shares of Royalty Pharma worth $38.1M as of Q3 2026.
  • Dimensional Fund Advisors sold 402,791 Royalty Pharma shares in Q3 2026, an estimated $23.8M.
  • Royalty Pharma made up 0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #1716 holding.
  • Dimensional Fund Advisors first reported a position in Royalty Pharma in Q1 2021 and has held it in 22 quarters since.
  • Dimensional Fund Advisors's Royalty Pharma position peaked at $89.4M in Q4 2025.
  • 275 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.